openPR Logo
Press release

Generic Drugs Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 8.1%

05-26-2024 12:36 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Generic Drugs Market

Generic Drugs Market

Allied Market Research has unveiled its latest research report titled 'Generic Drugs Market: Global Outlook and Forecast 2023-2030.' This extensive study not only assesses market risks but also illuminates numerous opportunities, providing crucial support for strategic decisions from 2023 to 2030. The report segments its market analysis into pivotal regions driving market growth. Readers will discover insightful details regarding market research and development, factors fostering growth, and the continuously evolving investment landscape within the global generic drugs market. Moreover, the report features profiles of several prominent companies, including Teva Pharmaceutical Industries, Hikma Pharmaceuticals, Cipla, Novartis, Aurobindo Pharma, GlaxoSmithKline, Amneal Pharmaceuticals, Viatris, Lupin, and Sun Pharmaceutical Industries.

Read More: https://www.globenewswire.com/en/news-release/2023/07/20/2708433/0/en/Generic-Drugs-Market-to-Reach-835-7-Billion-Globally-by-2032-at-8-1-CAGR-Allied-Market-Research.html

Generic Drugs Market Statistics: In 2022, the generic drugs market reached a valuation of $385.3 billion. Projections suggest it could hit $835.7 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2023 to 2032.

Key Drivers of Generic Drugs Market Growth:

Patent Expirations: As patents for brand-name drugs expire, it opens doors for generic versions, allowing manufacturers to introduce cost-effective alternatives, which drives market growth.

Cost-Effectiveness: Generic drugs are typically more affordable than their brand-name counterparts, making them more accessible to a broader population and stimulating market expansion.

Government Initiatives: Supportive government policies, including incentives for generic drug development and promotion of their use, contribute significantly to market growth.

Increasing Healthcare Expenditure: The rising healthcare costs prompt a shift toward generic drugs as they offer effective treatment options at lower prices, fostering market growth.

Rising Chronic Diseases: The prevalence of chronic diseases globally necessitates long-term medication, driving demand for cost-efficient generic drugs to manage these conditions.

Advancements in Manufacturing: Innovations in drug manufacturing technologies improve efficiency, reducing production costs and subsequently making generic drugs more economical.

Click To Get Sample Copy: https://www.alliedmarketresearch.com/request-sample/4140

The segments and sub-section of Generic Drugs market is shown below:

By Application: Cardiovascular, Infectious Diseases, Cancer, Diabetes, Arthritis, Central Nervous System Disorders, Others

By Route of Administration: Oral, Topical, Parenteral, Others

By Distribution Channel: Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers

Some of the key players involved in the Market are: Teva Pharmaceutical Industries, Hikma Pharmaceuticals, Cipla, Novartis, Aurobindo Pharma, GlaxoSmithKline, Amneal Pharmaceuticals, Viatris, Lupin, and Sun Pharmaceutical Industries.

Generic Drugs Market Dynamics and Transformations:
Economic Downturn Analysis: Impact of Recession in 2023
Pandemic's Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements

Important years considered in the Generic Drugs study:
Historical year - 2017-2021; Base year - 2021; Forecast period** - 2022 to 2030 [** unless otherwise stated]

If opting for the Global version of Generic Drugs Market; then below country analysis would be included:
- North America (USA, Canada and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
- Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Key Questions Answered in the Generic Drugs Market Study
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the Generic Drugs market in the forecast period?
What Factors are estimated to drive and restrain the Generic Drugs market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the Generic Drugs market?
What are the key companies operating in the Generic Drugs market?
Which company accounted for the highest market share?

Introduction about Generic Drugs Market
Generic Drugs Market Size (Sales) Market Share by Type (Product Category)
Generic Drugs Market by Application/End Users
Generic Drugs Sales (Volume) and Market Share Comparison by Applications
Global Generic Drugs Sales and Growth Rate (2020-2030)
Generic Drugs Competition by Players/Suppliers, Region, Type, and Application
Generic Drugs (Volume, Value, and Sales Price) table defined for each geographic region defined.
Generic Drugs Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
……..and view more in complete table of Contents

Procure Complete Report@ https://www.alliedmarketresearch.com/checkout-final/2145c80aa6c84897ff29c0098b1b767b

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Generic Drugs Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 8.1% here

News-ID: 3512768 • Views:

More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices. Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529 What Are Urinary Drainage Bags? Urinary drainage bags are specialized medical devices designed to collect
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031. The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Billion by 2030; Growing at a CAGR of 17.2%
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario. Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of 5.6%
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031. Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in

All 5 Releases


More Releases for Generic

Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth? The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall. Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs. The global generic drugs market is driven by the rise of
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems. At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of